KM Research Hub
← 返回论文库
待处理 入排:待复核 图源:待检查 入排置信度 0.45

Self-guided web-based mindfulness and skills-based distress reduction training versus treatment as usual optimised in patients with cancer (Reduct): a multicentre, parallel-group, randomised controlled trial.

Alexander Bäuerle, Julia Barbara Krakowczyk, You-Shan Feng, Peter Martus, Jana Maria Heinen, Donna Lienerth, Eva-Maria Skoda, Wolfgang Bethge, Andreas Dinkel, Michael Pantförder, Christoph Jansen, Anja Mehnert-Theuerkauf, Silke Neusser, Derek Spieler, Timm Dauelsberg, Jörg Wiltink, Alexander Wünsch, Tobias Geisel, Till Johannes Bugaj, Mitra Tewes, Dirk Schadendorf, Stephan Zipfel, Yesim Erim, Johanna Graf, Martin Teufel

BMJ Ment Health 29(1) e302908

PMID43034068
PMCIDPMC13775735
DOI10.1136/bmjment-2026-302908
发表日期2026-11-14
入排依据:未可靠识别 OS/PFS/DFS/EFS/RFS/TTP、Kaplan-Meier、HR 或其他 time-to-event 结局,需复核。
摘要

摘要

BACKGROUND: Electronic mental health (EMH) interventions in oncology offer low-threshold psychosocial support but efficacy research remains heterogeneous and lacking multicentre trials. OBJECTIVE: This trial assessed the efficacy of an EMH intervention compared with optimised treatment as usual (TAU-O) in reducing distress. METHODS: In this multicentre, parallel-group, randomised controlled trial, patients (18–65 years) with recent cancer diagnosis or progression (≤12 months) and elevated distress were recruited at eight university hospitals in Germany. Patients were randomly assigned (1:1) to the intervention or control condition. Randomisation was stratified by study centre using a computer-generated algorithm. The 16-week self-guided intervention provided structured psychosocial modules. TAU-O comprised psychosocial standard care and text-based digital information. The primary outcome was Hospital Anxiety and Depression Scale (HADS) total score at post-intervention (T1). Analyses were conducted in the intention-to-treat population using analysis of covariance adjusted for baseline and study centre, with multiple imputation for missing data. FINDINGS: Between 12 November 2021 and 22 April 2025, 1932 patients were assessed for eligibility, of whom 561 were randomly assigned (intervention n=281; control n=280) and included in the intention-to-treat population. The recruitment period was extended due to a 7-month recruitment pause following a cyberattack on the university’s information technology infrastructure. From baseline to T1, HADS scores decreased from 18.59 (SD 4.97) to 13.34 (6.67) in the intervention group and from 19.60 (5.43) to 15.13 (7.06) in the control group. The adjusted between-group difference in HADS score at T1 was −1.00 (95% CI −2.09 to 0.09; p=0.073) and not significant. Significant between-group differences were observed for the secondary outcomes anxiety symptoms and self-efficacy. No intervention-related adverse events occurred. CONCLUSIONS: Both groups improved over time, with no significant between-group difference in distress. Significant improvements in anxiety symptoms and self-efficacy in the intervention group compared with the control group suggest potential benefits for selected secondary outcomes, although these findings require further confirmation. CLINICAL IMPLICATIONS: Although the self-guided EMH intervention did not demonstrate superiority over optimised psychosocial cancer care in reducing distress, it may offer complementary benefits for selected mental health outcomes. EMH interventions may therefore be considered as adjuncts within stepped-care approaches. TRIAL REGISTRATION NUMBER: DRKS00025213.

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。